SpecificationsOrganism/cell line/tissue*Homo sapiens*/H1/human embryonic stem cellsSexMaleSequencer or array typeIllumina HumanHT-12 V4.0 expression beadchip (microarray)Data formatRaw and analyzedExperimental factorshESCs were incubated in either hESC medium or hESC medium without bFGF and TGFβ for 0, 48 and 96 h. hESCs were treated with either DMSO, Aphidicolin or Aphidicolin + AZD7762 or with either control or CCNB1 overexpression lentiviral constructs.Experimental featuresAnalysis of the effect of S phase arrest and replication checkpoint activation or Cyclin B1 overexpression on differentiating hESCs at the gene expression level.ConsentN/ASample source locationSingapore

1. Direct link to deposited data {#s0005}
================================

Deposited data can be found at <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62062> and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63215>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Cell culture {#s0015}
-----------------

The hESC line H1 (passage 30) was used for this study. They were cultured feeder-free on Matrigel (BD). hESCs were maintained by daily replenishment with mTeSR1 medium (STEMCELL Technologies). Routine subculture as clumps was executed when hESCs reach confluency every 4--5 days using 1 U/mL Dispase in DMEM/F12 (STEMCELL Technologies).

Prior to all treatments, hESCs were instead passaged as single cells using TrypLE™ Express (Life Technologies). 2 h after passage, treatments were applied. 24 h after treatment, medium was replaced to mTeSR1 without select growth factors (STEMCELL Technologies) to induce PSD ([Fig. 1](#f0005){ref-type="fig"}).

2.2. Experimental groups and conditions {#s0020}
---------------------------------------

To understand the effects of DNA replication perturbation and activation of the DNA damage checkpoint in hESCs undergoing PSD, we supplemented hESCs either with DMSO, with the DNA polymerase inhibitor Aphidicolin (75 ng/mL, Sigma), or with Aphidicolin plus the checkpoint kinase inhibitor AZD7762 (100 nM, SelleckChem).

To understand effects of Cyclin B1 overexpression in hESCs undergoing PSD, we infected hESCs either with the unmodified pLVTH vector or with the open reading frame of CCNB1 inserted using the PmeI and NdeI restriction sites. Lentiviral transduction was performed by addition of 2 μL of concentrated viruses to the culture medium with 4 μg/mL polybrene (Sigma).

Triplicate samples were prepared for each condition, and RNA was collected at 0, 48 and 96 h after induction of PSD ([Fig. 1](#f0005){ref-type="fig"}).

2.3. RNA extraction {#s0025}
-------------------

Cells were lysed with TRIzol® (Invitrogen) and RNA was extracted using standard chloroform-isopropanol procedure. RNAs were purified by DNAse I treatment (NEB) followed by column-purification using PureLink RNA Mini Kit (Ambion).

2.4. Microarray hybridization and analysis {#s0030}
------------------------------------------

250 ng of purified RNA was used to synthesize cDNA, followed by *in vitro* transcription for 14 h and cRNA purification, all using Illumina TotalPrep RNA Amplification Kit (Ambion). 750 ng of the purified biotin-labeled cRNA was used for hybridization for 18 h onto the HumanHT-12 v4 Expression BeadChips.

After hybridization, the raw images were obtained using Illumina BeadArray Reader. Rank invariant normalization and analysis were performed using GenomeStudio Software. Only probes with detection p-value \< 0.05 in all three replicates of at least one sample were considered for analysis. Differentially expressed genes were obtained using the Significance Analysis of Microarrays software (<http://statweb.stanford.edu/~tibs/SAM/>) and gene ontology analysis was done using DAVID (<https://david.ncifcrf.gov>/).

3. Discussion {#s0035}
=============

Dramatic biochemical and physical changes occur during progression through the cell cycle. Cells have evolved to utilize the differences between cell cycle phases to prime or regulate other processes that are not directly related to proliferation [@bb0030], [@bb0035], [@bb0040], [@bb0045]. We have demonstrated that interfering with DNA replication during the S phase or delaying progression in the G2 phase dominantly delays PSD [@bb0010]. Particularly, we find that the ATM/ATR-CHEK2-mediated DNA damage checkpoint and Cyclin B1 actively promote the pluripotent state in the S and G2 phases, respectively. To obtain a mechanistic connection between these pathways and pluripotency, we performed a time-course microarray analysis as described here. The datasets provided important information on the response of hESCs to DNA damage checkpoint activation, such as gene expression changes that lead to enhanced TGFβ signaling, which subsequently promotes the pluripotent state [@bb0015], [@bb0020], [@bb0025]. Similar changes were observed for Cyclin B1 overexpression, together with corresponding changes in mesoderm- and neuroectoderm-associated genes. In summary, our results demonstrate that the S and G2 phases possess an intrinsic propensity towards the pluripotent state, through active pathways that heighten TGFβ signaling. Knowledge on the regulatory network of PSD can be utilized to improve current differentiation protocols, and we hope that this resource will serve as a valuable tool for understanding PSD in hESCs and how this process is hardwired to the cell cycle.
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